Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 13, 2004
Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members
Orly Weinreb, Orit Bar-Am, Tamar Amit, et al.
Neurotoxicity Research
|
January 2, 2007
Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil
Moussa B H Youdim, Tamar Amit, Orit Bar-Am, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 30, 2009
Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis
Lana Kupershmidt, Orly Weinreb, Tamar Amit, et al.
Neuropharmacology
|
June 3, 2017
The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models
Tamar Amit, Orit Bar-Am, Danit Mechlovich, et al.
Chemico-Biological Interactions
|
July 5, 2008
The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity
Orly Weinreb, Orit Bar-Am, Tamar Amit, et al.
Antioxidants & Redox Signaling
|
November 23, 2006
The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection
Orly Weinreb, Noam Drigues, Yotam Sagi, et al.
Neurotoxicity Research
|
November 20, 2015
Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis
Sagit Golko-Perez, Silvia Mandel, Tamar Amit, et al.
Journal of Alzheimer'S Disease : JAD
|
October 28, 2008
Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG)
Silvia A Mandel, Tamar Amit, Limor Kalfon, et al.
Current Alzheimer Research
|
December 24, 2013
The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice
Danit Mechlovich, Tamar Amit, Orit Bar-Am, et al.
Journal of Neurochemistry
|
December 6, 2006
Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease
Yael Avramovich-Tirosh, Tamar Amit, Orit Bar-Am, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 13, 2004
Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members
Orly Weinreb, Orit Bar-Am, Tamar Amit, et al.
Neurotoxicity Research
|
January 2, 2007
Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil
Moussa B H Youdim, Tamar Amit, Orit Bar-Am, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 30, 2009
Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis
Lana Kupershmidt, Orly Weinreb, Tamar Amit, et al.
Neuropharmacology
|
June 3, 2017
The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models
Tamar Amit, Orit Bar-Am, Danit Mechlovich, et al.
Chemico-Biological Interactions
|
July 5, 2008
The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity
Orly Weinreb, Orit Bar-Am, Tamar Amit, et al.
Antioxidants & Redox Signaling
|
November 23, 2006
The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection
Orly Weinreb, Noam Drigues, Yotam Sagi, et al.
Neurotoxicity Research
|
November 20, 2015
Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis
Sagit Golko-Perez, Silvia Mandel, Tamar Amit, et al.
Journal of Alzheimer'S Disease : JAD
|
October 28, 2008
Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG)
Silvia A Mandel, Tamar Amit, Limor Kalfon, et al.
Current Alzheimer Research
|
December 24, 2013
The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice
Danit Mechlovich, Tamar Amit, Orit Bar-Am, et al.
Journal of Neurochemistry
|
December 6, 2006
Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease
Yael Avramovich-Tirosh, Tamar Amit, Orit Bar-Am, et al.
Page
of 9